Drug information for BESIVANCE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
SUSPENSION/DROPS; OPHTHALMIC EQ 0.6% BASE Prescription  (Reference Drug) BESIFLOXACIN HYDROCHLORIDE 7-((3R)-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid BAUSCH AND LOMB 22308
2009-07-10 Review

2009-07-10 Summary Review

2009-06-04 Label

2009-06-02 Letter

Drug Adverse Effects information for BESIVANCE

Role code Indications Reaction # Reports
PS CARPAL TUNNEL SYNDROME DYSGEUSIA 1
PS CARPAL TUNNEL SYNDROME FOREIGN BODY SENSATION IN EYES 1
PS CONJUNCTIVITIS DYSGEUSIA 3
PS CONJUNCTIVITIS FOREIGN BODY SENSATION IN EYES 3
PS CONJUNCTIVITIS BACTERIAL CONDITION AGGRAVATED 1
PS CONJUNCTIVITIS BACTERIAL EYE PAIN 1
PS CONJUNCTIVITIS BACTERIAL EYE SWELLING 1
PS CONJUNCTIVITIS BACTERIAL OCULAR HYPERAEMIA 1
PS DEPRESSION DYSGEUSIA 1
PS DEPRESSION FOREIGN BODY SENSATION IN EYES 1
PS POSTOPERATIVE CARE ENDOPHTHALMITIS 1
PS PREOPERATIVE CARE BLOOD URINE PRESENT 1
PS PRODUCT USED FOR UNKNOWN INDICATION BLOOD URINE PRESENT 1
PS PRODUCT USED FOR UNKNOWN INDICATION PAIN 1
PS PROPHYLAXIS ENDOPHTHALMITIS 1
SS POSTOPERATIVE CARE ENDOPHTHALMITIS 1
SS PROPHYLAXIS ENDOPHTHALMITIS 1
Ads by Google